Shushmita M. Ahmed, Alexandra Johns, Leah Timbang, Annie Wang, Navneet Kaur Singh, Victoria Lyo, Mohamed Ali
{"title":"COVID-19 的变化对代谢和减肥手术后的结果和社会经济差异的影响","authors":"Shushmita M. Ahmed, Alexandra Johns, Leah Timbang, Annie Wang, Navneet Kaur Singh, Victoria Lyo, Mohamed Ali","doi":"10.1007/s00464-024-11212-z","DOIUrl":null,"url":null,"abstract":"<h3 data-test=\"abstract-sub-heading\">Background</h3><p>We previously showed worse outcomes among lower socioeconomic status (SES) groups following metabolic/bariatric surgery (MBS). In light of healthcare changes in response to COVID-19, this study aims to evaluate post-pandemic MBS outcomes and determine if prior socioeconomic disparities persisted in the post-COVID era.</p><h3 data-test=\"abstract-sub-heading\">Methods</h3><p>A retrospective chart review of patients undergoing primary Roux-en-Y gastric bypass (RYGB) and sleeve gastrectomy (SG) between 2015 and 2022 was performed. Patients were stratified into pre- and post-COVID groups. Post-COVID cohort was further stratified into high (HT) and low (LT) tier status based on Distressed Communities Index, a geocoded composite measure of SES. Preoperative characteristics and postoperative outcomes were compared between pre- and post-COVID cohorts, as well as between post-COVID HT and LT groups.</p><h3 data-test=\"abstract-sub-heading\">Results</h3><p>Of 709 patients, 82.9% were pre-COVID and 17.1% were post-COVID. Post-COVID cohort had greater rate of public insurance (46% vs. 37%, <i>p</i> < 0.001), longer wait time to surgery (mean 358 ± 609.8 days vs 241.9 ± 368.5 days, <i>p</i> = 0.045), and were more likely to undergo RYGB (69% vs. 56%, <i>p</i> = 0.010). Post-COVID patients also had lower risk of any complications on multivariable analysis (OR 0.599, 95% CI 0.372–0.963), had higher follow-up rates at post-discharge (95.8% vs 79.7%, <i>p</i> < 0.005), 6-month (93% vs. 82%, <i>p</i> < 0.001) and 12-month visits (75% vs. 63%, <i>p</i> = 0.005), and lost more weight at 12 months (67% excess weight loss (%EWL) vs. 58%EWL, <i>p</i> = 0.002). Among post-COVID HT and LT cohorts, previously seen disparities in complications were no longer seen. Finally, there were no differences in weight or follow-up rates between post-COVID HT and LT.</p><h3 data-test=\"abstract-sub-heading\">Conclusions</h3><p>Post-COVID changes to MBS care have resulted in improved short-term outcomes and reduced disparities for patients of lower SES. Further studies are needed to identify these positive factors to perpetuate practice patterns that optimize care for patients of all socioeconomic status.</p>","PeriodicalId":501625,"journal":{"name":"Surgical Endoscopy","volume":"100 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-09-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Effect of COVID-19 changes on outcomes and socioeconomic disparities following metabolic and bariatric surgery\",\"authors\":\"Shushmita M. Ahmed, Alexandra Johns, Leah Timbang, Annie Wang, Navneet Kaur Singh, Victoria Lyo, Mohamed Ali\",\"doi\":\"10.1007/s00464-024-11212-z\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<h3 data-test=\\\"abstract-sub-heading\\\">Background</h3><p>We previously showed worse outcomes among lower socioeconomic status (SES) groups following metabolic/bariatric surgery (MBS). In light of healthcare changes in response to COVID-19, this study aims to evaluate post-pandemic MBS outcomes and determine if prior socioeconomic disparities persisted in the post-COVID era.</p><h3 data-test=\\\"abstract-sub-heading\\\">Methods</h3><p>A retrospective chart review of patients undergoing primary Roux-en-Y gastric bypass (RYGB) and sleeve gastrectomy (SG) between 2015 and 2022 was performed. Patients were stratified into pre- and post-COVID groups. Post-COVID cohort was further stratified into high (HT) and low (LT) tier status based on Distressed Communities Index, a geocoded composite measure of SES. Preoperative characteristics and postoperative outcomes were compared between pre- and post-COVID cohorts, as well as between post-COVID HT and LT groups.</p><h3 data-test=\\\"abstract-sub-heading\\\">Results</h3><p>Of 709 patients, 82.9% were pre-COVID and 17.1% were post-COVID. Post-COVID cohort had greater rate of public insurance (46% vs. 37%, <i>p</i> < 0.001), longer wait time to surgery (mean 358 ± 609.8 days vs 241.9 ± 368.5 days, <i>p</i> = 0.045), and were more likely to undergo RYGB (69% vs. 56%, <i>p</i> = 0.010). Post-COVID patients also had lower risk of any complications on multivariable analysis (OR 0.599, 95% CI 0.372–0.963), had higher follow-up rates at post-discharge (95.8% vs 79.7%, <i>p</i> < 0.005), 6-month (93% vs. 82%, <i>p</i> < 0.001) and 12-month visits (75% vs. 63%, <i>p</i> = 0.005), and lost more weight at 12 months (67% excess weight loss (%EWL) vs. 58%EWL, <i>p</i> = 0.002). Among post-COVID HT and LT cohorts, previously seen disparities in complications were no longer seen. Finally, there were no differences in weight or follow-up rates between post-COVID HT and LT.</p><h3 data-test=\\\"abstract-sub-heading\\\">Conclusions</h3><p>Post-COVID changes to MBS care have resulted in improved short-term outcomes and reduced disparities for patients of lower SES. Further studies are needed to identify these positive factors to perpetuate practice patterns that optimize care for patients of all socioeconomic status.</p>\",\"PeriodicalId\":501625,\"journal\":{\"name\":\"Surgical Endoscopy\",\"volume\":\"100 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-09-12\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Surgical Endoscopy\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1007/s00464-024-11212-z\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Surgical Endoscopy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1007/s00464-024-11212-z","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
背景我们曾发现,社会经济地位(SES)较低的群体在接受代谢/减肥手术(MBS)后的治疗效果较差。方法对2015年至2022年期间接受初级Roux-en-Y胃旁路术(RYGB)和袖状胃切除术(SG)的患者进行回顾性病历审查。患者被分为COVID前和COVID后两组。COVID后组群根据窘迫社区指数(SES的地理编码复合测量指标)进一步分为高(HT)层和低(LT)层。比较了COVID前和COVID后队列以及COVID后HT组和LT组的术前特征和术后结果。结果 在709名患者中,82.9%为COVID前患者,17.1%为COVID后患者。COVID后组的公共保险率更高(46% vs. 37%,p < 0.001),手术等待时间更长(平均 358 ± 609.8 天 vs 241.9 ± 368.5 天,p = 0.045),更有可能接受 RYGB(69% vs. 56%,p = 0.010)。在多变量分析中,COVID 后患者发生任何并发症的风险也更低(OR 0.599,95% CI 0.372-0.963),出院后随访率更高(95.8% vs 79.7%,p < 0.005)、6 个月(93% vs. 82%,p <0.001)和 12 个月随访(75% vs. 63%,p = 0.005)的随访率更高,12 个月时体重减轻的更多(超重体重减轻率 (%EWL) 为 67% vs. 58%EWL,p = 0.002)。在 COVID 术后 HT 和 LT 组群中,之前发现的并发症差异已不复存在。结论 COVID 后对 MBS 护理的改变改善了短期疗效,减少了较低社会经济地位患者的差异。需要进一步研究以确定这些积极因素,从而使针对所有社会经济地位患者的最佳护理实践模式得以延续。
Effect of COVID-19 changes on outcomes and socioeconomic disparities following metabolic and bariatric surgery
Background
We previously showed worse outcomes among lower socioeconomic status (SES) groups following metabolic/bariatric surgery (MBS). In light of healthcare changes in response to COVID-19, this study aims to evaluate post-pandemic MBS outcomes and determine if prior socioeconomic disparities persisted in the post-COVID era.
Methods
A retrospective chart review of patients undergoing primary Roux-en-Y gastric bypass (RYGB) and sleeve gastrectomy (SG) between 2015 and 2022 was performed. Patients were stratified into pre- and post-COVID groups. Post-COVID cohort was further stratified into high (HT) and low (LT) tier status based on Distressed Communities Index, a geocoded composite measure of SES. Preoperative characteristics and postoperative outcomes were compared between pre- and post-COVID cohorts, as well as between post-COVID HT and LT groups.
Results
Of 709 patients, 82.9% were pre-COVID and 17.1% were post-COVID. Post-COVID cohort had greater rate of public insurance (46% vs. 37%, p < 0.001), longer wait time to surgery (mean 358 ± 609.8 days vs 241.9 ± 368.5 days, p = 0.045), and were more likely to undergo RYGB (69% vs. 56%, p = 0.010). Post-COVID patients also had lower risk of any complications on multivariable analysis (OR 0.599, 95% CI 0.372–0.963), had higher follow-up rates at post-discharge (95.8% vs 79.7%, p < 0.005), 6-month (93% vs. 82%, p < 0.001) and 12-month visits (75% vs. 63%, p = 0.005), and lost more weight at 12 months (67% excess weight loss (%EWL) vs. 58%EWL, p = 0.002). Among post-COVID HT and LT cohorts, previously seen disparities in complications were no longer seen. Finally, there were no differences in weight or follow-up rates between post-COVID HT and LT.
Conclusions
Post-COVID changes to MBS care have resulted in improved short-term outcomes and reduced disparities for patients of lower SES. Further studies are needed to identify these positive factors to perpetuate practice patterns that optimize care for patients of all socioeconomic status.